SCHEMBL5157803

SCHEMBL5157803

CCCCCC=C([C]=O)CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.45
TSHR P16473 1/20 0.39
FAAH O00519 4/20 0.35
TRPV1 Q8NER1 1/20 0.35
TERT O14746 3/20 0.35
PTPN1 P18031 3/20 0.35
CYP1A2 P05177 2/20 0.35
MAPT P10636 2/20 0.35
CYP2C19 P33261 2/20 0.35
BLM P54132 2/20 0.35
HSD17B10 Q99714 2/20 0.35
FABP4 P15090 2/20 0.35
PPARG P37231 2/20 0.35
KMT2A Q03164 2/20 0.35
PPARD Q03181 2/20 0.35
PPARA Q07869 2/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5157798 1.00 EP300 (0.45) EP300TSHRFAAHTRPV1TERT
SCHEMBL4144615 0.84
SCHEMBL3041863 0.83 EP300 (0.47) EP300FAAHTERTPTPN1CYP1A2
SCHEMBL3041862 0.83 EP300 (0.47) EP300FAAHTERTPTPN1CYP1A2
SCHEMBL9652557 0.79 FAAH (0.47) FAAHTRPV1TERTPTPN1CYP1A2
SCHEMBL29190464 0.78 EP300 (0.41) EP300TSHRFAAHTERTPTPN1
SCHEMBL14809301 0.77 EP300 (0.44) EP300TSHRFAAHTRPV1TERT
SCHEMBL14809302 0.77 EP300 (0.44) EP300TSHRFAAHTRPV1TERT
SCHEMBL4130255 0.76 EP300 (0.47) EP300TSHRFAAHTRPV1TERT
SCHEMBL4130257 0.76 EP300 (0.47) EP300TSHRFAAHTRPV1TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742662-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES Astellas Pharma Inc. (JP) 2007-01-17 EP disclosed
WO-2005105147-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES ASTELLAS PHARMA INC. (JP) 2005-11-10 WO disclosed